Biohealth were meant to produce it locally for distribution and DFM were going to fund the millions needed to upgrade Biohealths facility so it was capable of the manufacture and production of Canntab. Now that DFM looks like its heading towards delisting I doubt this whole Canntab venture is viable anymore. I may be wrong but until CGB say otherwise that's the impression I get.
Biohealth were meant to produce it locally for distribution and...
Add to My Watchlist
What is My Watchlist?